Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epididymal angiosarcoma.

Matthew H Hayn1, Sheldon Bastacky, Michael E Franks

  • 1Department of Urology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA. haynm2@upmc.edu

Urology
|March 27, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Divergent TIR signaling domains in TLR7 and TLR9 control opposing effects on systemic autoimmunity.

The Journal of clinical investigation·2025
Same author

Inducible deletion of <i>Ezh2</i> in CD4<sup>+</sup> T cells inhibits kidney T cell infiltration and prevents interstitial nephritis in MRL/<i>lpr</i> lupus-prone mice.

iScience·2024
Same author

Inducible deletion of Ezh2 in CD4+ T cells inhibits kidney T cell infiltration and prevents interstitial nephritis in MRL/lpr lupus-prone mice.

bioRxiv : the preprint server for biology·2024
Same author

Purine nucleoside phosphorylase inhibition is an effective approach for the treatment of chemical hemorrhagic cystitis.

JCI insight·2024
Same author

Morphological characteristics of SETD2-mutated locally advanced clear cell renal cell carcinoma: Comparison with BAP1-mutated clear cell renal cell carcinoma.

Annals of diagnostic pathology·2023
Same author

B cell-intrinsic Myd88 regulates disease progression in murine lupus.

The Journal of experimental medicine·2023
Same journal

Editorial Comment on "A Histopathologic Assessment of Prostate Ductal Anatomy in Relation to Micro-Ultrasound".

Urology·2026
Same journal

Same-Day Discharge Following Multiport Robot-Assisted Simple Prostatectomy: A Prospective Feasibility Study of Outcomes, Costs, and Post-Discharge Healthcare Utilization.

Urology·2026
Same journal

Extended versus Standard Lymph Node Dissection at the Time of Radical Cystectomy for Bladder Cancer.

Urology·2026
Same journal

Intractable Epistaxis and Severe Hypertension in a Young Woman.

Urology·2026
Same journal

A 53-Year-Old Man with Elevated PSA and a Cystic Pelvic Lesion.

Urology·2026
Same journal

Low-Grade, Papillary Bladder Tumors A plea for in-office fulguration.

Urology·2026
See all related articles

This is the first reported case of angiosarcoma in the epididymis, a rare cancer originating from blood or lymph vessels. This finding highlights a potential, though uncommon, complication of prior radiation therapy.

Area of Science:

  • Oncology
  • Pathology

Background:

  • Sarcomas are rare malignancies, comprising about 1% of all cancer diagnoses.
  • Angiosarcoma, a subtype originating from vascular or lymphatic tissues, typically presents with a poor prognosis.
  • Previous radiation therapy is an established risk factor for secondary angiosarcoma development.

Observation:

  • An 80-year-old male patient presented with swelling in the right scrotum.
  • Diagnostic evaluation revealed an angiosarcoma originating in the epididymis.

Findings:

  • This case represents the first documented instance of angiosarcoma arising within the epididymis.
  • The patient's presentation with scrotal swelling was the primary clinical sign.

Implications:

Related Experiment Videos

  • This case expands the known anatomical sites for angiosarcoma development.
  • It underscores the importance of considering secondary malignancies, including angiosarcoma, in patients with a history of radiation therapy.
  • Further research may elucidate the specific mechanisms and incidence of epididymal angiosarcoma.